Current Cancer Drug Targets

Volume 1, Number 2, August 2001

Links for this Journal

Reviews

Selectively Replicating Adenoviruses for Oncolytic Therapy
pp. 85-107(22)
Authors: Yoon T-k.Laurent; Shichinohe T.; Laquerre S.; Kasahara N.

Links for this article

Selective Destruction of Tumor Cells through Specific Inhibition of Products Resulting from Chromosomal Translocations
pp. 109-119(12)
Authors: Rodriguez-Garcia A.; Sanchez-Martin M.; Perez-Losada J.; Perez-mancera P.A.; Sagrera-Aparisi A.; Gutierrez-Cianca N.; Cobaleda C.; Sanchez-Garcia I.

Links for this article

Mutant Cell Surface Receptors as Targets for Individualized Cancer Diagnosis and Therapy
pp. 121-128(9)
Authors: Becker K.Friedrich; Hofler H.

Links for this article

Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents
pp. 129-140(14)
Authors: Ghosh S.; Liu X.Ping; Zheng Y.; Uckun F.M.

Links for this article

Thymidine Phosphorylase: A Two-Face Janus in Anticancer Chemotherapy
pp. 141-153(14)
Authors: Focher F.; Spadari S.

Links for this article

Microarrays: Spotlight on Gene Function and Pharmacogenomics
pp. 155-175(21)
Authors: Nees M.; Woosworth C.D.

Links for this article